Covered recipient · General Payments record
LINDSEY COUNCIL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,025.58
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $233.85 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SHIELD THERAPEUTICS INC | $80.71 | 2 |
| Astellas Pharma US Inc | $79.04 | 3 |
| Novo Nordisk AS | $23.13 | 1 |
| Biogen, Inc. | $20.37 | 1 |
| ABBVIE INC. | $16.89 | 1 |
| Organon LLC | $13.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.89 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106957957 | CMS |
| Astellas Pharma US Inc | $24.52 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139501416 | CMS |
| Astellas Pharma US Inc | $28.53 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139462898 | CMS |
| Astellas Pharma US Inc | $25.99 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139548827 | CMS |
| Biogen, Inc. | $20.37 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104843574 | CMS |
| Novo Nordisk Inc | $23.13 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100583766 | CMS |
| Organon Llc | $13.71 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136297160 | CMS |
| SHIELD THERAPEUTICS INC | $18.40 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150126957 | CMS |
| SHIELD THERAPEUTICS INC | $62.31 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150150551 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.